-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 1 of 25
KARINE DUBÉ, DrPH Email: [email protected]
Cell Phone: (919) 259-2489
EDUCATION GILLINGS SCHOOL OF GLOBAL PUBLIC HEALTH UNIVERSITY OF
NORTH CAROLINA-CHAPEL HILL, NC Health Policy and Management (HPM)
Doctorate of Public Health (DrPH) Graduated in May 2016 OXFORD
UNIVERSITY, Oxford, England Master of Philosophy in Development
Studies/International Health (MPhil) Graduated in July 2005 with
Distinction
UNIVERSITY OF NORTH CAROLINA-CHAPEL HILL, NC B.A. in
International Studies, Concentration in Global Health Minor in
Business Administration (Kenan-Flagler Business School) GPA:
3.974/4.000. Graduated in May 2003 with Highest Honors
PROFESSIONAL EXPERIENCE 2017 – Present ASSISTANT PROFESSOR,
Public Health Leadership Program (PHLP),
SOCIO-BEHAVIORAL RESEARCHER, HIV Cure-Related Research
UNC-Chapel Hill Gillings School of Global Public Health
• Lead instructor for global health courses in the Public Health
Leadership Program (PHLP) and Global Health Concentration,
including:
o Introduction to Global Public Health (SPHG 700) (online) o
Critical Issues in Global Health (PUBH 711) (residential and
online) o Global Health Ethics (PUBH 712) (online) o AIDS Course
(PUBH 725) (online)
• Lead socio-behavioral scientist on HIV cure-related clinical
trial protocols 2016 ADJUNCT ASSISTANT PROFESSOR, Public Health
Leadership Program (PHLP),
UNC-Chapel Hill Gillings School of Global Public Health
• Lead instructor for global health courses in the Public Health
Leadership Program (PHLP) and Global Health Concentration,
including:
o Introduction to Global Public Health (SPHG 700) o Global
Health Ethics (PUBH 712)
2016 – 2017 CONSULTANT/CO-INVESTIGATOR, Social and Ethical
Aspects of HIV Cure Research (searcHIV), UNC-Chapel Hill, Chapel
Hill, NC
• Leading inter-disciplinary research and publications related
to the social sciences of HIV cure research in the United
States.
2016 CLINICAL PROJECT MANAGER, ClinicalRM, Chapel Hill, NC
• Managed all aspect of complex Ebola research program funded by
the Bill and Melinda Gates Foundation in West Africa, with a
special focus on natural history study of Ebola Virus Disease (EVD)
in Monrovia, Liberia.
• Managed the UNC – ClinicalRM – Duke – USAMRIID Ebola Research
Consortium.
mailto:[email protected]
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 2 of 25
2013 – 2015 RESEARCH PROGRAM MANAGER, Institute of Global Health
and Infectious Diseases (IGHID), Collaboratory of AIDS Researchers
for Eradication (CARE), The University of North Carolina at Chapel
Hill, NC.
• Managed a large NIH-funded Collaboratory compromised of 20+
scientists from 10+ universities in the United States and Europe
($USD 6.4 million/year) whose main objective was to pursue a
concerted effort to eradicate HIV infection by bringing a team of
experts together in discovery and development to create a cure for
AIDS. The Administrative Core was a key component for the success
of the Collaboratory by overseeing the various activities of the
research program and providing infrastructure and coordination
between the various scientific groups and the scientific cores.
• Designed and managed an international HIV cure research
training curriculum (CUREiculum) with partner organizations such as
DARE, defeatHIV, Project Inform, and AVAC.
• Built networks between the HIV+ community and the scientists
working on HIV cure-related research, convening meetings of
community advisory boards, disseminating information, and providing
community feedback to the scientists on their research.
2012 – 2013 CLINICAL RESEARCH ASSOCIATE III, U.S. Military HIV
Research Program (MHRP)/Henry M. Jackson Foundation for the
Advancement of Military Medicine, Inc. (HJF), Bethesda, MD.
• Managed site and cohort development program in preparation for
future prime-boost HIV vaccine trials in Mozambique, transitioned
project to U.S. Department of Defense and U.S. National Institutes
of Health Division of AIDS funding streams, developed and designed
HIV incidence research in Mozambique, prepared manuscripts for
Mozambique scientific journal articles, assisted in the preparation
of the U.S. Military HIV Research Program Clinical Trials Unit
application for the U.S. NIH DAIDS Clinical Research Sites
re-competition, developed standard operating procedures for MHRP
Clinical Operations Office.
2008 – 2012 SENIOR RESEARCH ASSOCIATE, FHI 360 (formerly Family
Health International), Research
Triangle Park, NC.
• Developed, designed and oversaw major components of studies in
infectious diseases, oversaw research implementation activities in
the field, prepared scientific reports, collaborated with team
members and field investigators throughout all phases of research,
oversaw submissions to ethical and institutional review boards,
developed and monitored financial aspects of studies, provided
technical oversight for preparation of proposals, protocols,
research instruments and study procedures manuals, developed and
reviewed protocols and study-related materials for assigned
clinical research studies, oversaw clinical monitoring of studies,
ensured that research was conducted in accordance with applicable
federal regulations and FHI 360 policies and standard operating
procedures, participated in clinical monitoring of studies, trained
junior research staff in clinical research monitoring and
management, assisted in development of research proposals and
business development.
2007 – 2008 RESEARCH AND PROGRAM ANALYST, amfAR – The Foundation
for AIDS Research, Washington, DC.
• Researched and analyzed biomedical and behavioral research
results, and compiled research developments pertaining to HIV/AIDS
prevention, treatment, care, and policy.
• Co-authored issue briefs, fact sheets and policy briefs on
various topics related to HIV/AIDS.
• Developed a strategic plan for the public policy
department.
• Assisted in the planning, development, and execution of
amfAR’s programmatic activities.
• Represented amfAR at meetings and conferences and promoted
amfAR’s positions and policy priorities to colleague organizations
and government agencies, including USAID, National Institutes of
Health (NIH), and Office of the Global AIDS Coordinator.
• Provided technical assistance to amfAR’s Therapeutics
Research, Education and AIDS Training (TREAT) Asia program.
• Created and maintained libraries of articles on several topics
related to HIV/AIDS for the organization.
• Conducted training workshops on HIV/AIDS-related issues;
supervised 5 junior staff.
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 3 of 25
2006 – 2007 PROGRAM COORDINATOR, Health Strategies
International, LLC, Durham, NC.
• Conducted consultancy work on human resources for malaria
scale-up activities for the Bill and Melinda Gates Foundation/PATH
Malaria Control and Evaluation Partnership (MACEPA) project in
Zambia.
• Provided technical assistance on USAID-funded Jamaica Health
Lifestyle Project and USAID-funded Romanian Health Care Reform
Project.
• Maintained project budgets and reviewed work plans, project
timelines and scopes of work.
• Acted as Manager of Business Development. Assisted in the
preparation of project proposals, including a successful
sub-contract on USAID/PATH TASC 2 Global Tuberculosis Task
Order.
• Expanded business relationships with partner organizations and
donors. Created a database of business opportunities and enrolled
the company with funders’ email list servers.
• Supervised 4 in-country staff. 2005 – 2006 SENIOR RESEARCH
ASSISTANT, Family Health International, Research Triangle Park,
NC.
• Clinical monitor for African sites conducting 6% Cellulose
Sulfate gel phase III trial. Verified source data, wrote and
resolved queries using electronic databases, reviewed the quality
and integrity of data collected from the sites.
• Maintained regulatory documents for multiple study sites and
ensured that the study was in accordance with GCP and other
international clinical guidelines.
• Served as the primary contact and coordinated correspondence
between the study sites, the sponsors and the in-house staff.
• Reviewed documents for successful implementation, coordination
and management of study projects.
HONORS 2015 Arthur B. Holzworth Endowed Scholarship in Health
Leadership, UNC-Chapel Hill 2005 Distinction (upon graduation),
Queen Elizabeth House, Oxford University 2003-2005 Rhodes
Scholarship 2003 Douglas Eyre International Studies Award (Best
Senior Honors Thesis) Robert E. Bryan Distinguished Service Award
2002 Jane Craig Gray Memorial Award (Most Outstanding Junior Woman)
James Henley Thompson & Evelyn Barnett Thompson Research Award
Order of the Golden Fleece Honor Society Order of the Old Well
Honor Society Ford Motor Company Golden Key Undergraduate
Scholarship 2001 Order of the Grail-Valkyries Honor Society Golden
Key National Honor Society 2000-2003 North Carolina Fellows Program
University of North Carolina Honors Program 1999-2003 Morehead
Scholarship Dean’s List (all semesters)
MEMBERSHIPS International AIDS Society (IAS) American Public
Health Association (APHA) – HIV/AIDS and Ethics Sections Consortium
of Universities for Global Health (CUGH) One Health
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 4 of 25
BIBLIOGRAPHY AND PRODUCTS OF SCHOLARSHIP
Submitted (Under Review) Journal Articles • K. Dubé, L. Hosey,
K. Starr, L. Barr, D. Evans, E. Hoffman, D.M. Campbell, J. Simoni,
J. Sugarman, J. Sauceda, B.
Brown, K.L. Diepstra, C. Godfrey, D.R. Kuritzkes, D.A. Wohl, R.
Gandhi, E. Scully. Perspectives in an HIV Cure-Related Trial
Conducted Exclusively in Women in the United States: Results from
AIDS Clinical Trials Group (ACTG) 5366. Submitted in AIDS Research
and Human Retroviruses (approximately 12 pages).
• K. Dubé, L. Dee. Willingness to Risk Death Endpoint in HIV
Cure-Related Research with Otherwise Healthy Volunteers is
Misleading. Submitted in Journal of Virus Eradication
(approximately 2 pages).
• K.E. Perry, K. Dubé, S. Concha-Garcia, H. Patel, A. Kaytes, J.
Taylor, S.S. Javadi, K. Mathur, M. Lo, B. Brown, J.A. Sauceda, D.A.
Wohl, S. Little, S. Hendrickx, S.A. Rawlings, D.M. Smith, S.
Gianella. “My Death Will Not [Be] in Vain”: Testimonials from Last
Gift Rapid Research Autopsy Study Participants Living with HIV at
the End of Life. Submitted in AIDS Research and Human Retroviruses
(approximately 12 pages).
• K. Dubé, H. Patel, S. Concha-Garcia, K.E. Perry, K. Mathur,
S.S. Javadi, J. Taylor, A. Kaytes, B. Brown, J.A. Sauceda, S.
Little, S. Hendrickx, S.A. Rawlings, D.M. Smith, S. Gianella. “What
Better Way to Leave this World”: Perceptions of Next-of-Kin/Loved
Ones about Last Gift Rapid Research Autopsy Study Enrolling People
with HIV/AIDS at the End of Life”. Submitted in AIDS Research and
Human Retroviruses (approximately 12 pages).
• P. Saberi, S. Eskaf, J.A. Sauceda, D. Evans, K. Dubé.
Perceptions of HIV Virologic Control Strategies among Younger and
Older Age Groups of People Living with HIV in the United States: A
Cross-Sectional Survey. Submitted in AIDS Research and Human
Retroviruses (approximately 12 pages).
• B. Brown, J. Taylor, K. Dubé, D. Kuzmanović, Y. Long, L. Marg.
Lessons Learned in the Ethical Conduct of HIV Research with
Community Members: A Case Study. Submitted in Ethics & Human
Research (approximately 8 pages).
In Press
• M. J. Peluso, L. Dee, D. Campbell, J. Taylor, R. Hoh, R.L.
Rutishauser, J. Sauceda, S. G. Deeks, K. Dubé. A Collaboratory,
Multi-Disciplinary Approach to Risk Mitigation during HIV
Analytical Treatment Interruption. In press in Journal of Virus
Eradication (approximately 3 pages).
Peer-Reviewed Journal Articles
1. M. Y. Karris, K. Dubé, A. A. Moore. What Lessons it Might
Teach Us! Community Engagement in HIV Research. Current Opinion in
HIV/AIDS 2020; 15(2): 142 – 49. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/31895141.
2. S. Tozay, W.A. Fischer, D.A. Wohl, K. Kilpatrick, F. Zou, E.
Reeves, K. Pewu, K. DeMarco, A.J. Loftis, K. King, D. Grant, J.
Schieffelin, G. Gorvego, H. Johnson, T. Conneh, G. Williams, J.A.E.
Nelson, D. Hoover, D. McMillian, C. Merenbloom, D. Hawks, K. Dubé,
J. Brown. Long-Term Complications of Ebola Virus Disease:
Prevalence and Predictors of Major Symptoms and the Role of
Inflammation. Clinical Infect Dis 2019 [Epub ahead of print]
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31693114.
3. K. Dubé, S. Eskaf, D. Evans, J. Sauceda, P. Saberi, B. Brown,
D. Averitt, K. Martel, M. Meija, D. Campbell, L. Barr, J.
Kanazawa, K. Perry, H. Patel, S. Luter, T. Poteat, J.D.
Auerbach, D.A. Wohl. The Dose Response: Perceptions of People
Living with HIV in the United States on Alternatives to Oral Daily
Antiretroviral Therapy. AIDS Research and Human Retroviruses 2019
[Epub ahead of print] PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/31608651.
https://www.ncbi.nlm.nih.gov/pubmed/31895141https://www.ncbi.nlm.nih.gov/pubmed/31693114https://www.ncbi.nlm.nih.gov/pubmed/31608651
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 5 of 25
4. K. Dubé, J. D. Auerbach, M. J. Stirratt, P. Gaist. Applying
the Functional Behavioral and Social Sciences Research (BRRS)
Framework to HIV Cure-Related Research. Journal of the
International AIDS Society (JIAS) 2019; 22: e25404. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/31665568.
5. L. Dee, C.A. Boone, D. Palm, D. Campbell, K. Dubé. Secondary
HIV Infection and Mitigation in Cure-Related HIV
Trials During Analytical Treatment Interruptions. Journal of
Infectious Diseases 2019; 220(7): 1230 – 1. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/31505661
6. B. Brown, L. Marg, Z. Zhang, D. Kuzmanović, K. Dubé, J.
Galea. Factors Associated with Payments to Research
Participants: A Review of Socio-Behavioral Studies at a Large
Southern California Research University. Journal of Empirical
Research on Human Research Ethics (JERHRE) 2019; 14(4): 408 – 15.
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31432735
7. K. Dubé, J. Simoni, M. Louella, L. Sylla, Z.H. Mohamed, H.
Patel, S. Luter, A.C. Collier. Acceptability of Cell and Gene
Therapy for Curing HIV Infection among People Living with HIV in
the Northwestern United States: A Qualitative Study. AIDS Research
and Human Retroviruses 2019 Apr 16. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/30990052
8. L. Newton, R. Necochea, D. Palm, J. Taylor, L. Barr, H.
Patel, A. Nathan, J. Gerrard, L. Sylla, B. Brown, K. Dubé.
Revisiting the ‘Sterilising Cure’ Terminology: A Call for More
Patient-Centered Perspectives on HIV Cure-Related Research. Journal
of Virus Eradication 2019; 5: 122 – 4. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/31191916.
9. M. M. Danielson, K. Dubé. Michael’s Testimonial. Annals of
Internal Medicine 2019; 170(7): 511 – 2. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/30934078
10. B. Julg, L. Dee, J. Ananworanich, D. Barouch, K. Bar, M.
Caskey, D. Colby, L. Dawson, K. Dong, K. Dubé, J. Eron, J. Frater,
R. Gandhi, R. Geleziunas, P. Goulder, G. Hanna, R. Jefferys, R.
Johnston, D. Kuritzkes, J. Li, U. Likhitwonnawut, J. van Lunzen, J.
Martinez-Picado, V. Miller, L. Montaner, D. Nixon, D. Palm, G.
Pantaleo, H. Peay, D. Persaud, J. Salzwedel, K. Salzwedel, T.
Schacker, V. Sheikh, O. Søgaard, S. Spudich, K. Stephenson, J.
Sugarman, J. Taylor, P. Tebas, C. Tiemessen, R. Tressler, C. Weiss,
S. Zheng, M. Robb, N. Michael, J. Mellors, S. Deeks, B. Walker.
Recommendations for Analytical Treatment Interruption in HIV
Remission Trials – Report of a Consensus Workshop. Lancet HIV 2019;
6(4): e259 – 68. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/30885693
11. K. Dubé, L. Barr, D. Palm, B. Brown, J. Taylor. Putting
Participants at the Centre of HIV Cure Research. Lancet HIV
2019; 6(3): e147 – 9. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/30772419
12. L. Overholt, D.A. Wohl, W. Fischer, D. Westreich, S. Tozay,
E. Reeves, K. Pewu, D. Adjasoo, D. Hoover, C. Merenbloom, J.
Johnston, G. Williams, T. Conneh, J. Diggs, A. Buller, D.
MacMillan, D. Hawks, K. Dubé, J. Brown. Stigma and Ebola
Survivorship in Liberia: Results from a Longitudinal Cohort Study.
PLoS One 2018; 13(11): e0206595. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/30485311
13. K. Dubé, S. Gianella, S. Concha-Garcia, S. Little, A.
Kaytes, J. Taylor, K. Mathur, S. Javadi, A. Nathan, H. Patel, S.
Luter, S. Philpott-Jones, B. Brown, D. Smith. Ethical
Considerations for HIV Cure-Related Research at the End of Life.
BMC Medical Ethics 2018; 19(1): 83. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/30342507
14. M.M. Danielson, K. Dubé. Michael’s Testimonial. Annals of
Internal Medicine 2018; 169(5): 349. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/30178018
15. B. Brown, C. Ortiz, K. Dubé. Assessment of the Right-to-Try
Law. Journal of Nuclear Medicine 2018; 59(1): 1 – 2. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/30097502
https://www.ncbi.nlm.nih.gov/pubmed/31665568https://www.ncbi.nlm.nih.gov/pubmed/31505661https://www.ncbi.nlm.nih.gov/pubmed/31432735https://www.ncbi.nlm.nih.gov/pubmed/30990052https://www.ncbi.nlm.nih.gov/pubmed/31191916https://www.ncbi.nlm.nih.gov/pubmed/30934078https://www.ncbi.nlm.nih.gov/pubmed/30885693https://www.ncbi.nlm.nih.gov/pubmed/30772419https://www.ncbi.nlm.nih.gov/pubmed/30485311https://www.ncbi.nlm.nih.gov/pubmed/30342507https://www.ncbi.nlm.nih.gov/pubmed/30178018https://www.ncbi.nlm.nih.gov/pubmed/30097502
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 6 of 25
16. K. Prakash, S. Gianella, K. Dubé, J. Taylor, G. Lee, DM.
Smith. Willingness to Participate in HIV Research at the End of
Life (EOL). PLoS One 2018; 13(7): e0199670. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/30036365
17. B. Brown, J. Galea, K. Dubé, P. Davidson, K. Khoshnood, L.
Holtzman, L. Marg, J. Taylor. The Need to Track Payment Incentives
to Participate in HIV Research. IRB: Ethics & Human Research
2018 (July – August). PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/30387975
18. K. Dubé, S. Luter, B. Lesnar, L. Newton, J. Galea, B. Brown,
S. Gianella. Use of ‘Eradication’ in HIV Cure-Related Research: A
Public Health Debate. BMC Public Health 2018; 18:245. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/29439706
19. K. Dubé, L. Sylla, L. Dee, J. Taylor, D. Evans, C.D. Bruton,
A. Gilbertson, L. Gralinski, B. Brown, A. Skinner, B. J. Weiner, S.
B. Greene, A. Corneli, A. Adimora, J.D. Tucker, S. Rennie. Research
on HIV Cure. Mapping the Ethics Landscape. PLoS Medicine 2017;
14(12): e1002470. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/29220353
20. L. Sylla, D. Evans, J. Taylor, A. Gilbertson, D. Palm, J.
Auerbach, K. Dubé. If We Build It, Will They Come? Perceptions of
HIV Cure Research by People Living with HIV in Four U.S. Cities – A
Qualitative Focus Group Study. AIDS Research and Human Retroviruses
2017. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29198134
21. K. Dubé, L. Sylla, L. Dee. Reply to Commentary: “Are HIV
Infected Candidates for Participation in Risky Cure-Related Studies
Otherwise Healthy.” Journal of Empirical Research on Human Research
Ethics (JERHRE) 2017. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/29179626
22. Brown B, Galea JT, Dubé K. Crucial but Understudied:
Incentives in HIV Research. Lancet HIV 2017. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/29170029
23. K. Dubé, L. Dee, D. Evans, L. Sylla, J. Taylor, B. Brown, V.
Miller, A. Corneli, A. Skinner, S. Greene, J. Tucker, S.
Rennie. Perceptions of Equipoise, Risk/Benefit Ratios, and
‘Otherwise Healthy Volunteers’ in the Context of Early-Phase HIV
Cure Research in the United States – A Qualitative Inquiry. Journal
of Empirical Research on Human Research Ethics (JERHRE) 2017.
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28984168
24. Fischer W.A. II, J. Brown, D. Wohl, A.J. Loftis, S. Tozay,
E. Reeves, K. Pewu, G. Gorvego, S. Quellie, C. K. Cunningham, C.
Merenbloom, S. Napravnik, K. Dubé, D. Adjasoo, E. Jones, K.
Bonarwolo, D. Hoover. Ebola Virus RNA Detection in Semen More than
Two Years after Resolution of Acute Ebola Virus Infection. Open
Forum Infectious Diseases 2017. Link:
https://www.ncbi.nlm.nih.gov/pubmed/29670927
25. K. Dubé, D. Evans, L. Dee, L. Sylla, J. Taylor, A. Skinner,
B.J. Weiner, S. B. Greene, S. Rennie, S. Greene. ‘We Need to Deploy
Them Very Thoughtfully and Carefully’: Perceptions of Analytical
Treatment Interruptions in HIV Cure Research in the United States –
A Qualitative Inquiry. AIDS Research and Human Retroviruses 2017.
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28562069
26. Garner S, S. Rennie, J. Ananworanich, K Dubé, D.M. Margolis,
J. Sugarman, R. Tressler, A. Gilbertson, L. Dawson.
Interrupting Antiretroviral Treatment in HIV Cure Research:
Scientific and Ethical Considerations. Journal of Virus Eradication
2017; 3: 82 – 4. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/28435691
27. K. Dubé, Taylor J., Sylla L., Evans D., Dee L., Burton A.,
Willenberg L., Rennie S., Skinner A., Tucker J.D., Weiner B.J.,
Greene S.B. ‘Well, It’s the Risk of the Unknown… Right?’: A
Qualitative Study of Perceived Risks and Benefits of HIV Cure
Research in the United States. PLoS One 2017; 12(1):e0170112.
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28122027
https://www.ncbi.nlm.nih.gov/pubmed/30036365https://www.ncbi.nlm.nih.gov/pubmed/30387975https://www.ncbi.nlm.nih.gov/pubmed/29439706https://www.ncbi.nlm.nih.gov/pubmed/29220353https://www.ncbi.nlm.nih.gov/pubmed/29198134https://www.ncbi.nlm.nih.gov/pubmed/29179626https://www.ncbi.nlm.nih.gov/pubmed/29170029https://www.ncbi.nlm.nih.gov/pubmed/28984168https://www.ncbi.nlm.nih.gov/pubmed/29670927https://www.ncbi.nlm.nih.gov/pubmed/28562069https://www.ncbi.nlm.nih.gov/pubmed/28435691https://www.ncbi.nlm.nih.gov/pubmed/28122027
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 7 of 25
28. K. Dubé, Evans D., Sylla L., Taylor J., Weiner B., Skinner
A., Thirumurthy H., Tucker J.D., Rennie S., Greene S. Willingness
to Participate in HIV Cure Research: Survey Results from 400 People
Living with HIV in the United States. Journal of Virus Eradication
January 2017; 3(1): 40 – 50. PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/28275457
29. Loftis A.J., S. Quellie, K. Chason, E. Sumo, M. Toukolon, Y.
Otieno, H. Ellerbrok, M.M. Hobbs, D. Hoover, K. Dubé, D.A. Wohl,
W.A. Fischer II. Validation of the Cepheid GeneXpert for Detecting
Ebola Virus in Semen. Journal of Infectious Diseases 2017; 215:
344-50. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27932614
30. Grossman C.I., A.L. Ross, J. D. Auerbach, J. Ananworanich,
K. Dubé, J. D. Tucker, V. Noseda, C. Possas, D. Rausch,
International AIDS Society Towards an HIV Cure Initiative.
Towards a Multi-Disciplinary HIV Cure Research Agenda: Integrating
the Social Science with Biomedical and Clinical Research. Trends in
Microbiology 2016; 24(1): 5 – 11. PubMed:
http://www.ncbi.nlm.nih.gov/pubmed/?term=26642901
31. K. Dubé, C. Ramirez, J. Handibode, J. Taylor, A. Skinner, S.
Greene, J. D. Tucker. Participation in HIV Cure Research: A Scoping
Review of the Proxy Literature and Implications for Future
Research. The Journal of Virus Eradication 2015; 1: e14-e20.
PubMed: http://www.ncbi.nlm.nih.gov/pubmed/26866059
32. J. Ananworanich, K. Dubé, N. Chomont. How Does the Timing of
Antiretroviral Therapy Initiation in Acute Infected Affect HIV
Reservoir? Current Opinion in HIV/AIDS 2015; 10(1): 18 – 28.
PubMed: http://www.ncbi.nlm.nih.gov/pubmed/25415421
33. Meque, K. Dubé, L. Bierhuizen, A. Zango, N. Veldhuijzen, F.
Cumbe, P.J. Feldblum, J. v.d. Wijgert. Willingness to Participate
in Future HIV Prevention Trials in Beira, Mozambique African
Journal of AIDS Research 2014; 13(4): 393 – 8. PubMed:
http://www.ncbi.nlm.nih.gov/pubmed/25555105
34. K. Dubé, G.E. Henderson, D.M. Margolis. Framing Expectations
in Early HIV Cure Research. Trends in Microbiology – Science and
Society 2014; 22(10): 547 – 9. PubMed:
http://www.ncbi.nlm.nih.gov/pubmed/25280965
35. P.J. Feldblum, S. Enosse, K Dubé, P. Arnaldo, C. Muluana, R.
Banze, A. Nhanala, J. Cunaca, P.-L. Chen, M.L. Robb, R. Thompson.
HIV Prevalence and Incidence in a Cohort of Women at Higher Risk
for HIV Acquisition in Chókwè, Southern Mozambique. PLoS One 2014;
9(5): e97547. PubMed:
http://www.ncbi.nlm.nih.gov/pubmed/24842811.
36. K. Nanda, A. Lendvay, C. Kwok, E. Tolley, K. Dubé, V.
Brache. Continuous Compared With Cyclic Use of Oral Contraceptive
Pills in the Dominican Republic. Obstetrics and Gynecology 2014;
123(5): 1012 – 22. PubMed:
http://www.ncbi.nlm.nih.gov/pubmed/24785854.
37. Meque, K. Dubé, P.J. Feldblum, A.C.A. Clements, A. Zango, F.
Cumbe, P.L. Chen, J.J. Ferro, J.H.v.d. Wijgert. Prevalence,
Incidence and Determinants of Herpes Simplex Virus Type 2 Infection
among HIV-Seronegative Women at High-Risk of HIV Infection: A
Prospective Study in Beira, Mozambique. PLoS One 2014; 9(2):
e89705. PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24586973.
38. K. Dubé, A. Zango, J.v.d. Wijgert, I. Meque, J.J. Ferro, F.
Cumbe, P.L. Chen, S. Ma., E Jolles, A. Fumo, M.L. Robb, P.J.
Feldblum. HIV Incidence in a Cohort of Women at Higher Risk in
Beira, Mozambique: Prospective Study 2009 – 2012. PLoS One 2014;
9(1): e84979. PubMed:
http://www.ncbi.nlm.nih.gov/pubmed/24475035.
39. K. Nanda, S. Delany-Moretlwe, K. Dubé, A. Lendvay, C. Kwok,
L. Molife, S.Nakubulwa, V. Edward, B. Mpairwe, F. Morembe.
Nevirapine-Based Antiretroviral Therapy Does Not Reduce Oral
Contraceptive Effectiveness. AIDS 2013; 27(Suppl 1): S17 – S25.
PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24088680.
https://www.ncbi.nlm.nih.gov/pubmed/28275457https://www.ncbi.nlm.nih.gov/pubmed/27932614http://www.ncbi.nlm.nih.gov/pubmed/?term=26642901http://www.ncbi.nlm.nih.gov/pubmed/26866059http://www.ncbi.nlm.nih.gov/pubmed/25415421http://www.ncbi.nlm.nih.gov/pubmed/25555105http://www.ncbi.nlm.nih.gov/pubmed/25280965http://www.ncbi.nlm.nih.gov/pubmed/24842811http://www.ncbi.nlm.nih.gov/pubmed/24785854http://www.ncbi.nlm.nih.gov/pubmed/24586973http://www.ncbi.nlm.nih.gov/pubmed/24475035http://www.ncbi.nlm.nih.gov/pubmed/24088680
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 8 of 25
40. Zango, K. Dubé, S. Kelbert, I. Meque, F. Cumbe, P.L. Chen,
J. Ferro, P.J. Feldblum, J.van de Wijgert. Determinants of
Prevalent HIV Infection and Late HIV Diagnosis among Young Women
with Two or More Sexual Partners in Beira, Mozambique. PLoS One
2013 8(5): e63427. http://www.ncbi.nlm.nih.gov/pubmed/23691046
41. K. Dubé, E. Hauser, C. Longfellow, A.C. Henley, W. Gesler.
Disability in North Carolina: Spatial Distributions and Access to
Care. North Carolina Geographer, Volume 11; 2003: 62-73. Available
at:
http://core.ecu.edu/crawfordt/ncgs/ncg/ncg_2003/2003_dube.pdf.
Fact Sheets/Technical Briefs 1. K. Dubé, E. Dunn-Georgiou, M.
Ruiz. Women and HIV/AIDS. amfAR Fact Sheet Number 2. March
2008.
2. M. Ruiz, K. Dubé, E. Dunn-Georgiou. HIV in Correctional
Settings: Implications for Prevention and Treatment
Policy. amfAR Issue Brief Number 5. March 2008. Presented at the
Second Annual Academic and Health Policy Conference on Correctional
Health Care.
3. M. Ruiz, K. Dubé, E. Dunn-Georgiou. The Effectiveness of Harm
Reduction in Preventing the Transmission of
HIV/AIDS. amfAR Fact Sheet Number 1. Revised November 2007.
4. M. Ruiz, K. Dubé, E. Dunn-Georgiou. Assessing the Efficacy of
Abstinence-Only Programs for HIV Prevention among Young People.
amfAR Issue Brief Number 2. Revised October 2007.
Invited Expert Panels 1. K. Dubé (with H. Peay, J. Sugarman, L.
Dawson, V. Miller, U. Likhitwonnawut). Ethics of Analytical
Treatment
Interruptions (ATIs)/Intensively Monitored Antiretroviral Pauses
(IMAPs). Consensus Workshop on Analytical Treatment Interruption in
HIV Cure Trials. Ragon Institute of MGH, MIT and Harvard. July
2018, Boston, MD, USA.
2. K. Dubé (with J.M. Zuniga, G. Bolan, S. Wilking, D. Harvey,
A. Reynolds, A.D. McNaugthen). Advances and
Interventions to End Epidemics The New Front Line of HIV, HCV,
and STD Prevention and Treatment. SYNChronicity 2018, April 2018,
Arlington, VA, USA.
3. K. Dubé (with N. Eyal, J. Sugarman, R. Steel, M. Agosto, D.
Evans) Regulation of Clinical Research Related to HIV
Cure. Expert panel on “Setting the Stage and Expectations for
Ethics and Community Engagement.” Forum for Collaborative Research,
January 2018, Bethesda, MD, USA.
4. K. Dubé (with E. Scully, K. Struble, D.D. Dixon). Regulation
of Clinical Research Related to HIV Cure. Expert panel on
“Population-Specific issues in HIV Cure Research: Women.” Forum for
Collaborative Research, January 2018, Bethesda, MD, USA.
Oral Presentations 1. K. Dubé. Women’s Involvement in HIV
Cure-Related Research – Empirical Data, Unresolved Challenges
and
Opportunities for the Future. Invited Oral Presentation at 2020
Pre-CROI Community HIV Cure Research Workshop, March 2020, Seattle,
WA, USA.
2. K. Dubé. Research Requiring Primary Data Collection. Invited
Lecture to Essentials of Practice-Based Research (HPM 953). March
2020. University of North Carolina at Chapel Hill, Chapel Hill, NC,
USA.
3. K. Dubé. When Ethics Must Keep Up with Fast-Paced Biomedical
Science: The Case of HIV Cure-Related Research. Invited lecture to
the UNC Chapel Hill Parr Centers for Ethics – Ethics around the
Table Series. February 2020. University of North Carolina at Chapel
Hill, Chapel Hill, NC, USA.
http://www.ncbi.nlm.nih.gov/pubmed/23691046http://core.ecu.edu/crawfordt/ncgs/ncg/ncg_2003/2003_dube.pdf
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 9 of 25
4. K. Dubé. Global Public Health Overview. Invited Lecture to
Introduction to Public Health (SPHG 600). November 2019. University
of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
5. B. Julg, L. Dee, K. Dubé. Analytical Treatment Interruptions
in HIV Cure-Related Research. Invited webinar to the AIDS Clinical
Trials Group (ACTG) Protocol Development and Implementation
Sub-Committee, November 2019.
6. K. Dubé, S. Eskaf, D. Evans, J. Sauceda, P. Saberi, B. Brown,
D. Averitt, K. Martel, M. Meija, D. Campbell, L. Barr, J. Kanazawa,
K. Perry, H. Patel, S. Luter, T. Poteat, J.D. Auerbach, D.A. Wohl.
Keeping HIV Under Control: A Cross-Sectional Survey on Preferences
for Virologic Control Strategies among People Living with HIV
(PLWHIV) in the United States. Oral presentation at 2019 American
Public Health Association (APHA) meeting. November 2019,
Philadelphia, PA, USA.
7. K. Dubé. Social Sciences and Ethics of HIV Cure. Invited oral
presentation for 2019 Research-for-Cure Academy hosted by
International AIDS Society (IAS) Towards an HIV Cure Initiative.
November 2019, Wits Rural Facility, South Africa.
8. R. Gandhi, K. Dubé. HIV Cure Research: An Overview of ACTG’s
Cure-Related Research and The Socio-Behavioral Aspects of
Cure-Related Research. Invited webinar presentation for Community
Partners and the Behavioral Science Working Group, October
2019.
9. D. M. Campbell, K. Dubé. Women and HIV Cure-Related Research.
Invited webinar presentation for BEAT-HIV Collaboratory, October
2019.
10. K. Dubé. Global Public Health Overview. Invited Lecture to
Introduction to Public Health (SPHG 600). July 2019. University of
North Carolina at Chapel Hill, Chapel Hill, NC, USA.
11. K. Dubé. How the Perspectives of People Living with HIV
Influence (or Don’t) the Design of Clinical Research. The Case of
HIV Cure. Invited oral presentation on ‘Community Engagement in HIV
Research’ Symposia at 2019 International AIDS Society Conference on
HIV Science, July 2019, Mexico City, Mexico.
12. K. Dubé. Integrating Social Sciences into BEAT-HIV Clinical
Trials. Invited oral presentation at 2019 BEAT-HIV Collaboratory
annual meeting, June 2019, Philadelphia, PA, USA.
13. K. Dubé. Women’s Interest in Participating in HIV
Cure-Related Research and Results from A5366 Participant Surveys.
Invited oral presentation to the 2019 AIDS Clinical Trials Group
(ACTG) annual meeting, Women and HIV Cure Research Symposium, Cure
Transformative Science Group (TSC) and Women’s Health Inter-Network
Scientific Committee (WHISC), June 2019, Washington, D.C., USA.
14. K. Dubé. Socio-Behavioral Sciences and Ethics in HIV
Cure-Related Research in the United States. A Review of Findings
and Possibilities. Invited oral presentation to the 2019 AIDS
Clinical Trials Group (ACTG) annual meeting, Protocol Development
and Implementation Committee (PDISC) and Community Scientific
Sub-Committee (CSS), June 2019, Washington, D.C., USA.
15. K. Dubé. End of Life Issues for People Living with HIV.
Invited oral presentation to the 2019 AIDS Clinical Trials Group
(ACTG) annual meeting, Mental Health and HIV Symposium, Neurology
Collaborative Science Group (Neuro CSG), June 2019, Washington,
D.C., USA.
16. K. Dubé, J. Taylor. The Last Gift. Update to Palm Springs
Positive Life Program. Invited oral presentation to the Palm
Springs Positive Life Program, May 2019, Palm Springs, CA, USA.
17. K. Dubé, S. Gianella. The Last Gift. Update to AntiViral
Research Center. Invited oral presentation to the AntiViral
Research Center, May 2019, San Diego, CA, USA.
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 10 of 25
18. K. Dubé. Integrating Social Sciences in HIV Cure-Related
Research/Intégrer les Sciences Sociales sur la Recherche pour une
Cure du VIH. Invited Oral Presentation at 2019 AIDS-ID Network
Scientific Conference/Journées Québécoises du VIH, April 2019,
Montréal, QC, Canada.
19. K. Dubé. Global Public Health Overview. Invited Lecture to
Introduction to Public Health (SPHG 600). April 2019. University of
North Carolina at Chapel Hill, Chapel Hill, NC, USA.
20. K. Dubé. HIV Cure Science Update/Fundamentals of HIV Cure
Research. Invited Oral Presentation for The Peter Doherty Institute
for Infection and Immunity, INSPIRE (Improve, Nurture and
Strengthen Education, Collaboration and Communication between
PLWHIV and REsearchers), March 2019, Melbourne, Australia.
21. K. Dubé. Enhancing Meaningful Engagement of Women Living
with HIV in Research. Invited Oral Presentation for Forum for
Positive Women Victoria, March 2019, Melbourne, Australia.
22. K. Dubé, M. Louella. HIV Cure Research Ethics Update –
Considerations for Cell and Gene Therapies. Invited Oral
Presentation at 2019 Pre-CROI Community HIV Cure Research Workshop,
March 2019, Seattle, WA, USA.
23. K. Dubé. Research Requiring Primary Data Collection. Invited
Lecture to Essentials of Practice-Based Research (HPM 953).
February 2019. University of North Carolina at Chapel Hill, Chapel
Hill, NC, USA.
24. K. Dubé. Global Public Health Overview. Invited Lecture to
Introduction to Public Health (SPHG 600). November 2018. University
of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
25. K. Dubé, D. Campbell, D. Evans. HIV Cure-Related Research.
What Does it Mean for Cisgender and Transgender Women Living with
HIV? Power Play: The Social and Scientific Impacts of Systematic
Disclusion of Women Living With or at Risk for HIV: From Research
to Praxis. Oral presentation at 2018 American Public Health
Association (APHA) meeting. November 2018, San Diego, CA, USA.
26. K. Dubé. Social Sciences and Ethics of HIV Cure. Invited
oral presentation for 2018 Research-for-Cure Academy hosted by
International AIDS Society (IAS) Towards an HIV Cure Initiative.
October 2018, Wits Rural Facility, South Africa.
27. K. Dubé. Social and Behavioral Sciences and Ethics Research:
Critical Adjuncts to Ongoing Biomedical HIV Cure-Related Research
Efforts. Invited webinar presentation for 2018 Community Meeting
hosted by European AIDS Treatment Group (ETAG) adjacent to Glasgow
HIV Drug Therapy Meeting, October 2018, Chapel Hill, NC USA and
Glasgow, Scotland.
28. K. Dubé. A Community-Friendly Conversation on HIV
Cure-Related Research: Hot Topics from Consensus Workshop on ATIs,
IAS 2018 and 2018 NIH-Sponsored Workshop on HIV Cure. Invited
webinar presentation for the I4C Martin Delaney Collaboratory
Towards an HIV Cure, October 2018, Chapel Hill, NC, USA.
29. K. Dubé. Pathway in Global Public Health – From
International Development to HIV Prevention and HIV Cure Research.
Invited Lecture to Exploring Public Health (SPHG 620). October
2018. University of North Carolina at Chapel Hill, Chapel Hill, NC,
USA.
30. M. Hermerding, V. Mason, K. Dubé, D. Evans, P. Goicochea, V.
Miller. Setting the Stage for Meaningful Community Engagement and
Participation in HIV Cure-Related Research: Lessons Learned from
the HIV Prevention Field. Oral presentation at HIV R4P (Research
for Prevention) 2018, October 2018, Spain, Madrid.
31. J. Sauceda, K. Dubé. The Next Frontier in Socio-Behavioral
Sciences and Ethics Research on HIV Cure. CAPS I&I Town Hall
and Round Table Discussion. University of California San Francisco,
October 2018, San Francisco, CA, USA.
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 11 of 25
32. K. Dubé, S. Luter, D. Evans. Acceptability of Target Product
Profiles for an HIV Cure Regimen According to Adults Living with
HIV in the United States. Invited oral presentation at 2018
NIH-sponsored workshop on HIV Cure, October 2018, Washington, D.C.,
USA.
33. M. Louella, L. Sylla, R. Boone, A.T. Young, K. Dubé. What Do
We Mean When We Say ‘HIV Cure’? Community
engagement session in International AIDS Society (IAS) 2018
Global Village, July 2018, Amsterdam, The Netherlands.
34. K. Dubé. What Do We Need for Outreach, Recruitment,
Retention, and Implementation of ACTG HIV Cure-Related Studies?
Invited presentation for AIDS Clinical Trials Group (ACTG) Protocol
Development and Implementation Sub-Committee (PDISC) annual
meeting, June 2018, Washington, D.C., USA.
35. K. Dubé. Women’s Participation in HIV Cure-Related Studies:
What is Needed to Mind the Gap? Invited presentation for AIDS
Clinical Trials Group (ACTG) Women’s Health Inter-Network
Scientific Committee (WHICS) annual meeting, June 2018, Washington,
D.C., USA.
36. K. Dubé. Perceptions of People Living with HIV on HIV
Cure-Related Research in the United States. Invited webinar for
AIDS Clinical Trials Group (ACTG) Outreach, Recruitment and
Retention (OR&R) Working Group. April 2018, United States.
37. K. Dubé. Ethical Issues in HIV Cure-Related Research.
Invited webinar for Clarkson University Bioethics Program. April
2018, United States.
38. K. Dubé, S. Deeks, D. Evans, J. Sugarman. Social and
Behavioral Sciences: A Critical Adjunct to Ongoing Biomedical HIV
Cure Research Efforts. Invited Oral Presentation for Brown Bag
Seminar Series, National Institutes of Health (NIH) Office of AIDS
Research (OAR). March 2018, Bethesda, MD, USA.
39. K. Dubé. Research Requiring Primary Data Collection. Invited
Lecture to Essentials of Practice-Based Research (HPM 953). March
2018. University of North Carolina at Chapel Hill, Chapel Hill, NC,
USA.
40. K. Dubé. Global Public Health Overview. Invited Lecture to
Introduction to Public Health (SPHG 600). February 2018. University
of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
41. K. Dubé, R. Ramaswamy. Great Decisions: Global Health
Progress and Challenges. February 2018. Invited Lecture to Great
Decisions Lecture Series (GLBL 381), University of North Carolina
at Chapel Hill, Chapel Hill, NC, USA.
42. K. Dubé. Perceptions of People Living with HIV on HIV
Cure-Related Research in the United States. Invited
webinar presentation to AIDS Clinical Trials Group (ACTG) HIV
Reservoirs and Viral Eradication Transformative Science Group
(TSG). February 2018, United States.
43. K. Dubé. Ethical Issues in HIV Cure-Related Research in the
United States. Invited Oral Presentation to HIV and
Global Health (HIGH) Rounds. February 2018, University of
California San Diego, CA, USA.
44. K. Dubé. Ethical Issues in HIV Cure-Related Research in the
United States. Invited Oral Presentation to Office of Research
Integrity (ORI) Seminar Series. February 2018, University of
California Riverside, CA, USA.
45. K. Dubé. Ethical Issues in HIV Cure-Related Research.
Invited Oral Presentation to Positive Life Program. February 2018,
Palm Springs, CA, USA.
46. K. Dubé. Ethical Issues in HIV Cure-Related Research at the
End-of-Life. Invited Oral Presentation to AntiViral Research Center
(AVRC) Community Advisory Board. February 2018, University of
California San Diego, CA, USA.
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 12 of 25
47. K. Dubé. HIV Cure Research Update. World AIDS Day Event,
International Civil Rights Center & Museum. Invited Oral
Presentation, December 2017, Greensboro, NC, USA.
48. K. Dubé. Social Sciences Agenda in HIV Cure-Related Research
in the United States. Invited Oral Presentation for the BEAT-HIV
Collaboratory, Wistar Institute, November 2017, Philadelphia, PA,
USA.
49. K. Dubé. HIV Cure-Related Research and the Socio-Behavioral
Research Agenda. Invited Oral Presentation at Center for AIDS
Research (CFAR) Social and Behavioral Research Network (SBSNR) 11th
National Scientific Meeting, October 2017, San Francisco, CA,
USA.
50. K. Dubé. Social Sciences in HIV Cure-Related Research. Where
are We and Where Should we Go? Invited webinar presentation for the
amfAR Institute for HIV Cure Research, October 2017, Chapel Hill,
NC, USA.
51. K. Dubé. Translating HIV Cure Research Discoveries into
People: A Community Conversation. Invited webinar presentation to
Collaboratory of AIDS Researchers for Eradication (CARE), October
2017, Chapel Hill, NC, USA.
52. D. Campbell, J. Patterson, D. Evans, P. Goicochea, M.
Agosto, D. Averitt, J. Salzwedel, C. Ramirez, K. Dubé. Where Are We
with an HIV Cure Strategy for Women? Workshop at United States
Conference on AIDS, September 2017, Washington, D.C., USA.
53. K. Dubé. Social Sciences in HIV Cure-Related Research: Where
are We and Where Should be Go? Invited webinar presentation to the
Delaney AIDS Research Enterprise (DARE), September 2017, Washington
D.C., USA.
54. K. Dubé. Perceptions and Ethics of Treatment Interruptions
in HIV Cure Research in the United States. Invited Oral
Presentation at Cell and Gene Therapy Meeting, August 2017,
Seattle, WA, USA.
55. K. Dubé. “From One Pill a Day to No Pill a Day:” Bridging
Biomedical and Social Sciences in HIV Cure Research in the United
States. Invited Oral Presentation at FHI 360, February 2017,
Durham, NC, USA.
56. K. Dubé, D. Evans, L. Dee, L. Sylla, J. Taylor. Research
into Community Perspectives on HIV Cure Science. Invited Oral
Presentation at 2017 Pre-CROI Community HIV Cure Research Workshop,
February 2017, Seattle, WA, USA.
57. K. Dubé. Opinions about HIV Cure Research among People
Living with HIV in the United States. Invited Oral Presentation at
2016 Women’s HIV Research Initiative on HIV/AIDS (WRI) annual
meeting, December 2016, Palmetto Bluff, South Carolina, USA.
58. L. Sylla, J. Taylor, D. Evans, D. Palm, A. Gilbertson, K.
Dubé. HIV Cure Research: What Trial Participants Want
Researchers to Know. Oral presentation at the 2016 Cell and Gene
Therapy Meeting, August 2016, Seattle, USA.
59. K. Dubé, J. Taylor, D. Evans, L. Sylla, L. Dee, A. Skinner,
H. Thirumurthy, B. Weiner, S. Rennie, S. Greene. Factors Affecting
Participation in HIV Cure-Related Research in the United States:
Implications for Effective and Ethical Implementation. Oral
presentation at the 2016 “Towards an HIV Cure Symposium”, July
2016, 2016 International AIDS Society, Durban, South Africa.
60. S. Rennie, S. Garner, K Dubé. Is It Ethical to Interrupt HIV
Treatment in HIV Cure Research Studies? Oral
presentation at the 2016 Canadian Bioethics Society Conference,
May 2016, Toronto, Canada.
61. K. Dubé, J. Taylor, D. Evans, L. Sylla, A. Burton, A.
Skinner, S. Greene. Emerging Results of an Extensive Survey of
Potential Participants' Willingness to Take Risks in and Donate to
HIV Cure Research in the United States, 7th HIV Persistence
Workshop, December 2015, Miami, FL, USA.
62. K. Dubé. Decoding HIV Cure Science: A CUREiculum Seminar.
Oral Presentation at United States Conference on
AIDS, September 2015, Washington, D.C., USA.
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 13 of 25
63. K. Dubé. START Trial Results and Implications and Early
Antiretroviral Therapy – A CUREiculum Presentation.
Invited Presentation at the Annual Meeting of the AIDS Clinical
Trials Group (ACTG), June 2015, Washington, D.C.
64. K. Dubé. Examining Participation in HIV Cure Trials. What
Can We Learn from the Proxy Literature? Oral Presentation at
Brocher Foundation Workshop on “Unintended and Intended
Implications of HIV Cure: A Social and Ethical Analysis.” May 2014,
Geneva, Switzerland.
65. K. Nanda, F. Mirembe, K. Dubé, A. Lendvay, C. Kwok, L.
Molife, S. Nakubulwa, V. Edward, S. Delany-Moretlwe.
Nevirapine-Containing ART Does Not Reduce Combined Oral
Contraceptive Effectiveness: Results from South Africa and Uganda.
Oral presentation 2012 International Virology Education Workshop on
HIV and Women, February 2012, Toronto, Canada.
66. Zango, L. Bierhuizen, N. Veldhuijzen. A. Gova. F. Cumbe, K.
Dubé, P. Feldblum, J. van de Wijgert. Men’s Willingness to
Participate in Future HIV Prevention Trials in Beira, Mozambique.
Oral presentation at Microbicides 2012, April 2012, Sydney,
Australia.
67. R. Thompson, J. Ferro, S. Enosse, I. Meque, C. Muluana, A.
Zango, P. Arnaldo, K. Dubé, T. Clifton, J. van de
Wijgert, P. Feldblum. Social and Epidemiological Characteristics
of Women Most at Risk for HIV Infection in Mozambique. Oral
presentation at 2011 INTEREST workshop, May 2011, Dar es Salaam,
Tanzania.
Poster Presentations
1. K. Dubé, J. D. Auerbach, M. J. Stirratt, P. Gaist. From
Reservoirs to the Real World. A Framework for Integrating
Behavioral and Social Sciences Research into Biomedical HIV
Cure-Related Research. Poster presentation at 2019 HIV Persistence
During Therapy – Reservoirs & Eradication Strategies Workshop,
December 2019, Miami, FL.
2. K. Perry, J. Taylor, S. Concha-Garcia, S. Javadi, H. Patel,
A. Kaytes, S. Little, D. Smith, S. Gianella, K. Dubé. Behind the
Scenes: Clinical and Rapid Autopsy Staff Members’ Experiences and
Perceptions of HIV Reservoir Research at the End of Life. Poster
presentation at 2019 HIV Persistence During Therapy – Reservoirs
& Eradication Strategies Workshop, December 2019, Miami,
FL.
3. B. Brown, L. Marg, Z. Zhang, D. Kuzmanović, K. Dubé, J.
Galea. Factors Associated with Payments to Research Participations:
A Review of Sociobehavioral Studies at a Large Southern California
Research University. Poster presentation at 2019 Public
Responsibility in Medical Research (PRIM&R), November 2019,
Boston, MA.
4. J. S. Y. Lau, M. Z. Smith, B. Allan, K. Dubé, A. T. Yong, J.
Power. The INSPIRE Project: Improving Community and Stakeholder
Involvement in HIV Cure-Focused Research. Poster presentation at
2019 Australasian HIV & AIDS Conference, September 2019, Perth,
Australia.
5. T. Poteat, K. Dubé, A. Aqil, D. Evans. Transgender Women’s
Perceptions of HIV Cure Research: Qualitative Interviews with
Transgender Women Living with HIV in Baltimore, MD, United States.
Poster presentation at 2019 HIV & HBV Cure Forum, International
AIDS Society Towards an HIV Cure Symposium, July 2019, Mexico City,
Mexico.
6. K. Dubé, A. Nathan, K. Mathur, S. Concha-Garcia, H. Patel, A.
Kaytes, J. Taylor, D. Smith, S. Gianella. Altruism in End of Life
HIV Research: Insights from Last Gift Study. Posted presentation at
2019 Conference on Retroviruses and Opportunistic Infections
(CROI), March 2019, Seattle, Washington, USA.
7. J. Simoni, L. Sylla, M. Louella, H. Patel, S. Luter, A.C.
Collier, K. Dubé. Acceptability of Cell and Gene Therapies for
Curing HIV: A Qualitative Investigation among Persons Living with
HIV (PLWH) in the Northwestern United States. Poster presentation
at 2018 NIH-sponsored workshop on HIV Cure, October 2018,
Washington, D.C., USA.
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 14 of 25
8. K. Dubé, A. Nathan, S. Concha-Garcia, H. Patel, A. Kaytes, J.
Taylor, D. Smith, S. Gianella. Extraordinary Altruism Displayed in
HIV Cure-Related Research at the End of Life (EOL). Insights from
Last Gift Study Participants. Poster presentation at 2018
NIH-sponsored workshop on HIV Cure, October 2018, Washington, D.C.,
USA.
9. K. Dubé, H. Patel, S. Concha-Garcia, A. Nathan, B. T. Miller,
A. Kaytes, J. Taylor, D. Smith, S. Gianella. Perceptions of
Next-of-Kin/Loved Ones about Last Gift Study Participation at the
End of Life. Poster presentation at 2018 NIH-sponsored workshop on
HIV Cure, October 2018, Washington, D.C., USA.
10. D. Evans, L. Sylla, J. Taylor, L. Dee, M. Louella, K. Dubé.
The Critical Importance of Social Sciences in Early-Phase
HIV Cure Research: What’s in It for Biomedical HIV Cure
Scientists? Poster presentation at 2017 HIV Persistence during
Therapy – Reservoirs and Eradication Strategies Workshop, December
2017, Miami, FL, United States.
11. K. Dubé, L. Sylla, L. Dee, J. Taylor, D. Evans, C. Bruton,
A. Gilbertson, L. Gralinski, B. Brown, A. Skinner, B.J.
Weiner, S.B. Greene, A. Corneli, A. Adimora, J.D. Tucker, S.
Rennie. Towards a Translational Ethics of HIV Cure Research –
Mapping the Landscape. Poster presentation at 2017 Global Health
Triangle Consortium conference, September 2017, Raleigh, NC, United
States.
12. K. Dubé, L. Sylla, D. Evans, J. Taylor, D. Palm, A.
Gilbertson, J. D. Tucker, J. Auerbach. ‘From One Pill a Day to No
Pill a Day’: Perceptions of HIV Cure Research among People Living
with HIV – Qualitative Findings from Focus Groups in 4 U.S. Cities.
Poster presentation at 2017 International AIDS Society conference,
July 2017, Paris, France.
13. L. Sylla, M. Louella, D. Evans, D. Palm, R. Jefferys, K.
Dubé. What Would an HIV Cure Mean to You? Ascribing Meaning through
an HIV Cure Tree. Poster presentation at 2017 International AIDS
Society conference, July 2017, Paris, France.
14. K. Dubé, J. Taylor, D. Evans, L. Sylla., L. Dee. Perceived
Motivators, Deterrents, Concerns and Barriers Related to HIV Cure
Research Participation in the United States: A Qualitative Study.
Poster presentation at 2016 NIH-sponsored workshop on HIV Cure,
November 2016, Washington, D.C., USA.
15. L. Sylla, D. Evans, J. Taylor, D. Palm., A. Gilbertson, K.
Dubé. ‘We’re scared… and brave’: Potential Study
Participant Expectations of HIV Cure Researchers. Poster
presentation at 2016 NIH-sponsored workshop on HIV Cure, November
2016, Washington, D.C., USA.
16. K. Dubé, B. Weiner, J. Taylor, S. Garner, S. Rennie. Is
There an Implementation Ethics to HIV Cure-Related
Research? Poster presentation at 2016 AIDS conference, July
2016, Durban, South Africa.
17. D. Evans, J. Taylor, L. Sylla, S. Garner, B. Weiner, A.
Skinner, S. Greene, S. Rennie, K. Dubé. Treatment Interruptions in
HIV Cure Studies in the United States: Perceptions, Motivations and
Ethical Considerations from Potential HIV-Positive Volunteers. Oral
poster presentation at 2016 AIDS conference, July 2016, Durban,
South Africa.
18. J. Taylor, D. Evans, L. Sylla, L. Dee, B. Weiner, A.
Skinner, S. Greene, K. Dubé. Perceived Risks of Participating
in
HIV Cure-Related Research in the United States. Poster
presentation at 2016 AIDS conference, July 2016, Durban, South
Africa.
19. J. Taylor, D. Evans, L. Sylla, L. Dee, B. Weiner, S. Greene,
S. Rennie, K. Dubé. “What is “Too Much Risk” in HIV
Cure Clinical Research in the United States. Poster presentation
at 2016 AIDS conference, July 2016, Durban, South Africa.
20. L. Sylla, J. Taylor, D. Evans, B. Weiner, A. Skinner, S.
Greene, K. Dubé. Perceived Benefits of HIV Cure-Related
Research Participation in the United States. Poster presentation
at 2016 AIDS conference, July 2016, Durban, South Africa.
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 15 of 25
21. J. Salzwedel, S. Hannah, J. Taylor, K. Dubé. Community
Engagement in HIV Cure-Related Research: Applying
Good Participatory Practice (GPP) Principles to Community
Education Efforts. Oral poster presentation at 2016 AIDS
conference, July 2016, Durban, South Africa.
22. S. Garner, S. Rennie, J. Ananworanich, K. Dubé, D. Margolis,
J. Sugarman, R. Tressler, A. Gilbertson, L. Dawson.
Interruption Antiretroviral Treatment in HIV Cure Research:
Scientific and Ethical Considerations. Oral poster presentation at
2016 AIDS conference and poster presentation at “Towards an HIV
Cure Symposium”, July 2016 Durban, South Africa.
23. K. Dubé, J. Taylor, R. Jefferys, M. Sharp, S. Wakefield, J.
Handibode. Results of a Community Needs Assessment
and Pilot Test of a Novel HIV Cure Research Training Curriculum.
Poster presentation at the 2015 “Towards an HIV Cure Symposium”,
2015 International AIDS Society, July 2015, Vancouver, Canada.
24. C. Garrido, J.M. Sung, N. Archin, B. Allard, K. Dubé, J.
Kuruc, C. Gay, S. A. Stanfield-Oakley, J. Pickeral, J. Pollara,
C. LaBranche, M. Bonsignori, M. A. Moody, R. Parks, J. Blum,
C.-Y. K. Lam, L. Liu, S. Johnson, S. Koenig, K. Sodenberg, H.X.
Liao, D. Montefiori, J. Nordstrom, B. F. Haynes, G Ferrari, M.
Cohen, D. Margolis. Dual Affinity Re-Targeting (DARTs) Molecules to
Improve Immune Mediated Clearance of HIV Latent Reservoir. Poster
presentation at 2014 NIH-sponsored Strategies for an HIV Cure
meeting, October 2014, Bethesda, M.D., USA.
25. K. Nanda, V. Brache, C. Kwok, B. Tolley, A. Lendvay, K.
Dubé. Continuous versus Cyclic Use of Combined Oral
Contraceptive Pills. Poster presentation at 2012 Society and
Family Planning Conference, July 2012, Denver, CO, USA.
26. R. Thompson, S. Enosse, C. Muluana, P. Arnaldo, A. Nhanala,
A. Bié, K. Dubé, P. L. Chen, M. Robb, K. Walker, P.
Feldblum. Measurement of HIV Incidence in a Higher-Risk Cohort
in Southern Mozambique. Poster presentation at 2012 AIDS
conference, July 2012, Washington, D.C., USA.
27. N.B. Bhatt, I.V. Jani, R. Thompson, J. Ferro, S. Enosse, A.
Zango, K. Dubé, P. Feldblum, J. van de Wijgert, M. Robb,
K. Walker. Building Novel Clinical Research Capacity in
Resource-Limited Settings: Lessons Learned at Three Mozambique
Sites. Poster presentation at 2012 Drug Information Association
(DIA) Conference, June 2012, Philadelphia, PA, USA.
28. Zango, K. Dubé, P.L. Chen, I. Meque, F. Cumbe, J. Ferro, S.
Fischer, R. Krysiak, P. Feldblum, J. van de Wijgert. Correlations
between CD4 Lymphocyte Counts and BED-CEIA HIV-1 Incidence Test
Outcomes in Beira, Mozambique. Poster presentation at 2012 INTEREST
workshop, May 2012, Mombasa, Kenya.
29. Meque, K. Dubé, A, Zango, P.L. Chen, F. Cumbe, J. Ferro, P.
Feldblum, J. van de Wijgert. HSV-2 Infection among Women at Higher
Risk for HIV Infection in Preparation for HIV Prevention Trials in
Beira, Mozambique. Poster presentation at 2012 INTEREST workshop,
May 2012, Mombasa, Kenya.
30. Meque, K. Dubé, A. Zango, P.L. Chen, J. Ferro, P. Feldblum,
F. Cumbe, J. van de Wijgert. HIV Incidence Among Women at Higher
Risk in Beira, Mozambique. Poster presentation at 2012
Microcrobicides, April 2012, Sydney, Australia.
31. K. Dubé, R. Thompson, I. Meque, S. Enosse, C. Muluana, A.
Zango, J. Ferro, T. Clifton, J. van de Wijgert, P.
Feldblum. Unmet Need for Family Planning among HIV-Positive
Women in Mozambique – Cross-Sectional Surveys in Beira and Chókwè.
Poster presentation at 2011 IAS conference, July 2011, Rome,
Italy.
32. Zango, P. Arnaldo, K. Dubé, R. Thompson, J. Ferro, S.
Enosse, I. Meque, S. Fischer, J. van de Wijgert, P. Feldblum.
Performance of a Rapid Test Algorithm for Confirming HIV Serostatus
in Beira and Chókwè, Mozambique. Poster presentation at 2011 IAS
conference, July 2011, Rome, Italy.
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 16 of 25
33. J. Ferro, I. Meque, A. Zango, S. Mussa, R. Rafael, K. Dubé,
J. Conjera, J. Bos, P. Feldblum, J. van de Wijgert. Main Social and
Epidemiological Features of Women Enrolled in a Cross-Sectional
Survey in Beira, Mozambique. Poster presentation at 2010 INTEREST
workshop, May 2010, Maputo, Mozambique.
34. R. Rafael, J. Conjera, S. Mussa, J. Ferro, I. Meque, K.
Dubé, J. Bos, J. van de Wijgert, P. Feldlbum. Lessons Learned
from Community Recruitment into a Cross-Sectional Survey
Involving HIV Testing in Beira, Mozambique. Poster presentation at
2010 INTEREST workshop, May 2010, Maputo, Mozambique.
35. K. Dubé, S. Mussa, A. Zango, I. Meque, J. Conjera, J. Ferro,
J. Bos, P. Feldblum, J. van de Wijgert. Lessons Learned
from Building Research Capacity for Phase III HIV Prevention
Trials in Beira, Mozambique. Poster presentation at 2010
Microbicides Conference, May 2010, Pittsburg, PA, United
States.
Sample Blog Posts • How Do We Get to a Global Cure? (Positively
Aware):
https://www.positivelyaware.com/articles/how-do-we-get-global-cure
• Highlights from the International AIDS Society HBV/HIV Cure
Research Forum:
https://www.positivelyaware.com/articles/highlights-ias-hbvhiv-cure-research-forum
• CROI 2019 HIV Cure Research Highlights: Has a Second Person
Been Cured of HIV and 2019 Pre-CROI Community HIV Cure Research
Workshop Summary (Positively Aware):
https://www.positivelyaware.com/articles/hiv-research-highlights
• 2018 NIH Strategies for an HIV Cure – Meeting Highlights:
https://www.positivelyaware.com/articles/2018-nih-strategies-hiv-cure
• IAS 2018 HIV Cure Research Highlights:
https://www.positivelyaware.com/articles/aids-2018-hiv-cure-research-highlights
• Applying the Ethical Payment Framework: We Need Data:
https://blog.primr.org/ethical-payment-framework-data/
• Mental Health Gets Special Emphasis at CROI 2018:
https://www.positivelyaware.com/articles/mental-health-gets-special-emphasis-croi-2018
• Update from HIV Persistence 2017 – HIV Cure Scientific
Highlights from the 2017 HIV Persistence Meeting:
https://www.positivelyaware.com/articles/update-hiv-persistence-2017
• Positively Aware – HIV Cure Survey Results: We asked: ‘What
Does a Cure for HIV Mean to You?:
https://www.positivelyaware.com/articles/hiv-cure-survey-results
• Going into 2018: Reflections on Global Health Security:
https://sph.unc.edu/global-health/going-into-2018-reflections-on-global-health-security/
• Carl June: Keynote at the 2017 Cell and Gene Therapy Meeting:
http://searchiv.web.unc.edu/carl-june-keynote-2017-cell-gene-therapy-meeting/
• Snapshots of the 2017 Oxford Global Health and Bioethics
International Conference:
https://sph.unc.edu/global-health/snapshots-of-the-2017-oxford-global-health-and-bioethics-international-
conference
• IAS 2017: HIV and Cancer Fields United in Dialogue to
Accelerate Discovery in the Search towards ‘Sustained Virologic
Remission’:
http://searchiv.web.unc.edu/ias-2017-hiv-cancer-fields-united-dialogue-accelerate-discovery-search-towards-sustained-virologic-remission/
https://www.positivelyaware.com/articles/how-do-we-get-global-curehttps://www.positivelyaware.com/articles/highlights-ias-hbvhiv-cure-research-forumhttps://www.positivelyaware.com/articles/hiv-research-highlightshttps://www.positivelyaware.com/articles/2018-nih-strategies-hiv-curehttps://www.positivelyaware.com/articles/aids-2018-hiv-cure-research-highlightshttps://blog.primr.org/ethical-payment-framework-data/https://www.positivelyaware.com/articles/mental-health-gets-special-emphasis-croi-2018https://www.positivelyaware.com/articles/update-hiv-persistence-2017https://www.positivelyaware.com/articles/hiv-cure-survey-resultshttps://sph.unc.edu/global-health/going-into-2018-reflections-on-global-health-security/http://searchiv.web.unc.edu/carl-june-keynote-2017-cell-gene-therapy-meeting/https://sph.unc.edu/global-health/snapshots-of-the-2017-oxford-global-health-and-bioethics-international-%09conferencehttps://sph.unc.edu/global-health/snapshots-of-the-2017-oxford-global-health-and-bioethics-international-%09conferencehttp://searchiv.web.unc.edu/ias-2017-hiv-cancer-fields-united-dialogue-accelerate-discovery-search-towards-sustained-virologic-remission/http://searchiv.web.unc.edu/ias-2017-hiv-cancer-fields-united-dialogue-accelerate-discovery-search-towards-sustained-virologic-remission/
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 17 of 25
TEACHING ACTIVITIES
Semester Course Number of Students
Summer 2020 The AIDS Course (PUBH 725) Public Health Leadership
Program, UNC Chapel Hill (online)
TBD
Fall 2019 Critical Issues in Global Health (PUBH 711) Public
Health Leadership Program and Global Health Concentration, UNC
Chapel Hill (residential)
42
Summer 2019 The AIDS Course (PUBH 725) Public Health Leadership
Program, UNC Chapel Hill (online)
15
Spring 2019 Global Health Ethics (PUBH 712) Public Health
Leadership Program, UNC Chapel Hill (online)
20
Fall 2018 Critical Issues in Global Health (PUBH 711) Public
Health Leadership Program, UNC-Chapel Hill (online)
38
Summer 2018 The AIDS Course (PUBH 725) Public Health Leadership
Program, UNC Chapel Hill (online)
10
Spring 2018 Global Health Ethics (PUBH 712) Public Health
Leadership Program, UNC Chapel Hill (online)
22
Fall 2017 Critical Issues in Global Health (PUBH 711) Public
Health Leadership Program, UNC-Chapel Hill (online)
26
Fall 2017 Introduction to Global Public Health (SPHG 700) Public
Health Leadership Program, UNC-Chapel Hill (online)
8
Spring 2017 Global Health Ethics (PUBH 712) Public Health
Leadership Program, UNC-Chapel Hill (online)
25
Fall 2016 Introduction to Global Public Health (SPHG 700),
Public Health Leadership Program, UNC-Chapel Hill (online)
20
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 18 of 25
STUDENT MENTORING Doctoral Dissertations
1. Joseph L. Barker, DrPH (Cohort 14), Optimizing Public Health
Strategies to Increase HIV Testing Services among Men in Kenya,
DrPH Dissertation Committee Member; under development.
2. Mayra Serrano, DrPH (Cohort 14), Assessing the Effectiveness
of the Promotora Model to Increase Latino Participation in Cancer
Research, DrPH Dissertation Committee Member; under
development.
3. Olawale Durosinmi-Etti, DrPH (Cohort 13), Improving Funding
Sustainability for HIV Treatment Services in Nigeria, DrPH
Dissertation Committee Member; under development.
4. Courtney Lundquist, DrPH (Cohort 12), Achieving 90-90-90:
Defining, Adapting, and Applying Lessons to Accelerate Goal
Achievement, DrPH Dissertation Committee Member; successfully
defended October 2019.
Graduate Teaching Assistants 2019
1. Dana Corbett, Critical Issues in Global Health (PUBH 711) 2.
Elsa Sanabria, Global Health Ethics (PUBH 712) and AIDS Course
Online (PUBH 725)
2018 2. Aninda Sen, Critical Issues in Global Health (PUBH 711)
3. Breanne Lesnar, Global Health Ethics (PUBH 712)
2017 4. Breanne Lesnar, Introduction to Global Public Health
(SPHG 700) 5. Luke Newton, Critical Issues in Global Health (PUBH
711)
Graduate Research Assistants 2019
1. Karen Diepstra, PhD Candidate, UNC Epidemiology (R21-
MH118120)
Research Assistants 2019 – Present
1. Kelly Perry, Public Health Leadership Program, UNC Gillings
School of Global Public Health (Last Gift cohort) 2. Laney Henley,
Bachelor’s in Biostatistics, UNC Gillings School of Global Public
Health (A5345)
2018 – Present 3. Hursch Patel, Health Policy and Management,
UNC Gillings School of Global Public Health (Last Gift cohort)
2018 – 2019 4. Anshula Nathan, Public Health Leadership Program,
UNC Gillings School of Global Public Health (Last Gift
cohort) 5. Maria Ganama, Public Health Leadership Program, UNC
Gillings School of Global Public Health (A5366)
2017 – Present 6. Stuart Luter, Health Policy and Management,
UNC Gillings School of Global Public Health 7. Kushagra Mathur,
University of California, San Diego (Last Gift cohort) 8. Sogol
(Stephanie) Javadi, University of California, San Diego (Last Gift
cohort) 9. Megan Lo, University of California, San Diego (Last Gift
cohort)
Student Collaborators 2017 – 2018
1. Melissa Hermerding, University of California, Berkeley, Forum
for Collaborative Research
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 19 of 25
Research Mentees 2020
1. Nimali Widanage, Sri Lanka Medical Council, Sri Lanka (2019
International AIDS Society Research-for-Cure Academy Fellow)
2. Samantha Fry, Stellenbosch University, South Africa (2019
International AIDS Society Research-for-Cure Academy Fellow)
2019
3. Danielle M. Campbell, Research Instructor, Charles R. Drew
University (CDU) of Medicine and Science 4. Lentsu Nchabeleng,
Nelson Mandela University, South Africa (2018 IAS Research-for-Cure
Academy Fellow)
STUDENT ADVISING/MENTORING 1. Tandeka Burks, MPH at UNC
(Online), Leadership in Practice (2020 – present) 2. Makala
Carrington, MPH at UNC (Online), Leadership in Practice (2020 –
present) 3. Madeline Pliska, MPH at UNC (Online), Leadership in
Practice (2020 – Present) 4. Grace Anixter, MPH Residential Degree
in Public Health Leadership – UNC Asheville (2019 – present) 5.
Chandra Anjali, MPH at UNC (Online), Leadership in Practice (2019 –
present) 6. Annie Lakey Becker, MPH at UNC (Online), Leadership in
Practice (2019 – present) 7. Emily Cheng, MPH Residential Degree,
Concentration in Global Health (2019 – present) 8. Cloie Chiong,
MPH at UNC (Online), Leadership in Practice (2019 – present) 9.
Patrick David Lilford Glasgow, MPH at UNC (Online), Leadership in
Practice (2019 – Present) 10. Erica Liedtke, MPH Residential Degree
in Public Health Leadership – UNC Asheville (2019 – present) 11.
Jonathan Andrew Metz, MPH at UNC (Online), Leadership in Practice
(2019 – Present) 12. Katerina Pattee, MPH Residential Degree,
Concentration in Global Health (2019 – present) 13. Jennifer Page
(Prater) Quesenberry, MPH at UNC (Online), Leadership in Practice
(2019 – present) 14. Nadine Rammouni, MPH at UNC (Online),
Leadership in Practice (2019 – present) 15. Alexandra Voss, MPH at
UNC (Online), Leadership in Practice (2019 – present) 16. Kelly
Perry, MPH at UNC (Online), Leadership in Practice (2019 – present)
17. Taylor LLyall, MPH at UNC (Online), Leadership in Practice
(2019 – present) 18. Hector (Kenett) Melgar Mendoza, MPH
Residential Degree in Public Health Leadership – UNC Asheville
(2018 –
present) 19. Cat Turbyfill, MPH Residential Degree in Public
Health Leadership – UNC Asheville (2018 – present) 20. Sarah
Elizabeth Ashley, MPH Residential Degree in Public Health
Leadership (2017 – 2019) 21. Erica Brierley, MPH Residential Degree
in Public Health Leadership (2017 – 2018) 22. Rachel Davidson,
Global Online (GO)TM MPH Program (2017 – present) 23. Grace Greene,
Global Online (GO)TM MPH Program (2017 – present) 24. Mandy Horner,
MPH Residential Degree in Public Health Leadership (2017 – 2018)
25. Victoria Pless, MPH Residential Degree in Public Health
Leadership (2017 – 2019) 26. Mariana Rodriguez, MPH Online Degree
in Public Health Leadership (2017 – present)
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 20 of 25
Master’s Papers Supervision: 2020
1. Courtney George: Title to be confirmed (Second reader). 2.
John Kanazawa: Title To be confirmed (First reader). 3. Hannah
Webster: “A Scoping Review and Comparison of International Media
Attention and Local Media Contact
and Its Implications Associated with the 2015 Zika Outbreak in
Latin America” (Second reader) 2019
1. Grace Greene: “Pre-Eclampsia amongst Pregnant Women in Haiti:
The Impact of Micronutrient Supplementation” (First reader)
2. Rachel Davidson, “Baseline Assessment to Evaluate Attitudes,
Norms, Knowledge, and Behaviors around Violence against Women and
Girls and Evidence-Based Practices for the Curricula of a
Faith-Based Youth Organization [in Kenya]” (First reader)
3. Sarah Elizabeth Ashley: “Developing Emergency Medicine
Leaders for Public Health Outcomes in East Africa” (First
reader)
4. Maria Ganama: “Sustainability of HIV/AIDS Treatment in
Nigeria Through Domestic Production of Antiretroviral Treatment”
(First reader)
5. Victoria Pless: “Reducing the Proportion of Children Living
in Poverty in Dauphin County, Pennsylvania: A Program Plan Using
Agile Strategy and Collective Impact” (First reader)
6. Anshula Nathan: “Undetectable = Untransmittable (U = U)
Implementation in Rural North Carolina: Lessons Learned from
Successful Rural Health Promotion and Education Campaigns” (Second
reader)
7. Thomas Porter: “HIV Pre-Exposure Prophylaxis (PrEP) and
Sexually Transmitted Infections (STI) Testing: Recommendations for
Expanded Access and Public Health Implications in North Carolina”
(Second reader)
2018 6. Erica Brierley: “Sexual Harassment Whistleblowing in the
Uganda Health Workforce” (First reader)
OTHER MENTORING Teaching – Adjunct Faculty 2019
1. Christie Pettitt-Schieber, Adjunct Faculty, Public Health
Leadership Program, Chapel Hill, NC. Undergraduate Students 2019 –
Present
1. J. Eduardo Neri, Morehead-Cain Scholar (2017 – 2021),
University of North Carolina, Chapel Hill, NC.
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 21 of 25
CONTRACTS AND GRANTS
Ongoing Research Support 11/01/2019 – present (0% effort) A
Phase I Study to Evaluate the Safety and Antiviral Activity of Two
Human Monoclonal Antibodies (VRC07-523LS and PGT121LS) Administered
to HIV Infected Participants Who Initiated ART During Acute or
Chronic HIV-1 Infection, AIDS Clinical Trials Group (ACTG) Study
5389 Role: Socio-Behavioral Scientist 10/01/2019 – present (5%
effort) City of Hope (COH)/California Institute for Regenerative
Medicine (CIRM) – Participant-Centered Outcomes for CMV-HIV
Chimeric Antigen Receptor (CAR) T Cell Protocol (development phase)
Role: Socio-Behavioral Scientist 07/01/2019 – present (5% effort) A
Pilot Phase I Randomized Study to Evaluate Innate Immune Activation
Predictors of Sustained Viral Control in HIV-Infected Adults
Undergoing a Brief Analytical Treatment Interruption after the
Administration of Pegylated Interferon Alpha 2b in Combination with
Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and
10-1074 (BEAT-HIV Collaboratory) Role: Socio-Behavioral Scientist
05/01/2019 – 03/31/2021 (30% effort) Pilot Integration of
Participant-Centered Outcomes in HIV Cure Research in the United
States: Implications for Ethical Conduct (R21 MH118120) Role:
Principal Investigator/Project Director 02/01/2019 – TBD (0%
effort) The INSPIRE Project: Improve, Nurture and Strengthen
Education, Collaboration, and Communication between People Living
with HIV and REsearchers. In collaboration with the Australian
Research Center in Sex, Health and Society, La Trobe University,
Melbourne, Australia Role:
Co-Investigator/Consultant/Socio-Behavioral Scientist 10/01/2018 –
TBD (10% effort) Combinatorial Therapy with [CONFIDENTIAL]: A Pilot
Study Aimed at Inducing an HIV Remission, UCSF/amfAR Institute for
HIV Cure Research. Role: Socio-Behavioral Scientist 08/01/2018 –
TBD (0% effort) A Phase 1, Open-Label, Study of the Safety,
Pharmacokinetics and Ability to Durably Prevent Viral Relapse
During a Monitored Analytical Treatment Interruption of a
Combination of the Broadly Neutralizing Antibodies 3BNC117-LS and
10-1074-LS, AIDS Clinical Trials Group (ACTG) Study 5364 Role:
Socio-Behavioral Scientist 08/01/2017 – 07/31/2022 (5% effort)
Revealing Reservoirs during Rebound (R3) P01AI131385 Role:
Socio-Behavioral Scientist 08/01/2017 – TBD (0% effort)
Identification of Biomarkers to Predict Time to Plasma HIV RNA
Rebound and Post-Treatment Viral Control during an Intensively
Monitored Antiretroviral Pause (IMAP), AIDS Clinical Trials Group
(ACTG) Study 5345/5347s Role: Socio-Behavioral Scientist
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 22 of 25
08/01/2017 – TBD (0% effort) Selective Estrogen Receptor
Modulators to Enhance the Efficacy of Viral Reactivation with
Histone Deacetylase Inhibitors, AIDS Clinical Trials Group (ACTG)
Study 5366 Role: Socio-Behavioral Scientist
Completed Research Support 07/01/2017 – 04/30/2019 (5% effort)
Clinical Sequelae and Urogenital Viral Dynamics in Survivors of
Ebola Virus Disease in Liberia NIH R01 AI123535 Role: Research
Support 03/01/2017 – 07/31/2017 ($USD 10,000 direct) Gilead
Sciences/Project Inform Social Sciences of HIV Cure Research in the
United States Role: Co-Investigator
02/02/2017 – 09/14/2017 ($USD 13,000 direct) Social and Ethical
Implications of HIV Cure Research (searcHIV) NIH R01A108366 Role:
Co-Investigator/Consultant 01/01/2016 – 06/30/2016 ($USD 5,000
direct) Martin Delaney Collaboratory National Community Advisory
Board/University of California San Francisco (UCSF) Focus Group
Implementation for Social Sciences in HIV Cure Research in 4 U.S.
Cities (Seattle,CA; Los Angeles, CA; San Diego, CA; Durham, NC)
Role: Principal Investigator 01/01/2016 – 06/30/2016 ($USD 14,479
direct) Martin Delaney Collaboratory National Community Advisory
Board/University of California San Francisco (UCSF) Role:
Co-Lead
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 23 of 25
Previous Work Experience and Research Protocol Involvement
Program Management of the Collaboratory of AIDS Researchers for
Eradication (CARE) (2013 – 2015) Research Program Manager
Responsibilities included provision of strategic and administrative
direction to a large U.S. National Institutes of Health (NIH)
Division of AIDS (DAIDS)-funded Collaboratory comprised of 20+
scientific projects from 10+ universities in the United States and
Europe, together with industry partner Merck Inc. Main tasks
pertained to overall grant management, fiscal management and
oversight for cooperative agreement, management of internal
communications including webinar series, coordination of scientific
groups, production of operational reports and updates, coordination
of external communications, including CARE Scientific Advisory
Board, NIH, CARE Community Advisor Board (CAB) and other Martin
Delaney Collaboratories, planning of face-to-face meetings;
knowledge management including CARE-related publications and
website, regular assessment of CARE investigators’ research
progress, outcomes and collaboration; management of shared
resources and reagents and coordination of legal and intellectual
property rights agreement. The major focus of the CARE is on the
development and testing of therapeutic interventions to eradicate
latent HIV infection (www.delaneycare.org). Funded by the NIH
DAIDS, Bethesda, United States. Cohort and Site Development to
Assess the Incidence of HIV Infection, Retention Rate, and
Willingness of Adults to Participate in Future HIV Vaccine Trials
in Mozambique (2012 – 2013) Lead Clinical Research Associate
Responsibilities included site development and capacity building,
project management and elaboration of implementation plans,
development of critical project documents, writing of manuscripts
and scientific journal articles, development of general and
study-specific training curriculums for site and cohort development
project, communications with external partners. Funded by U.S.
Department of Defense (DoD) and NIH DAIDS, Bethesda, United States.
Clinical Site Development Initiative – Mozambique; Combined
Cross-Sectional and Prospective Study for Measurement of HIV
Incidence in Beira, Mozambique and in Chókwè, Mozambique (2008 –
2012) Project Manager/Senior Clinical Research Manager/Technical
Monitor Responsibilities included site development and capacity
building, management of study progress and implementation plans,
development of critical study documents, submission for scientific
and ethical reviews, elaboration and management of budgets and
contracts, supervision of FHI 360/North Carolina and FHI
360/Mozambique staff, Good Clinical Practice (GCP) clinical
monitoring, training of site staff, communication with external
partners including the Amsterdam Institute of Global Health and
Development (AIGHD)/AfrEVacc and the University of Pittsburgh
(Beira), and the United States Military HIV Research Program
(MHRP)/Henry M. Jackson Foundation for the Advancement of Military
Medicine and the U.S. Centers for Disease Control and Prevention
(CDC)/Mozambique. Funded by United States Agency for International
Development (USAID); European and Developing Countries Clinical
Trials Partnership (EDCTP), Amsterdam; U.S. MHRP, United States.
Project Management of Interactions between Antiretrovirals and
Combined Oral Contraceptive Pills (2008 – 2012) Co-Project
Manager/Site Manager Responsibilities included development of study
documents, project management, supervision of clinical monitors,
GCP clinical monitoring of research site (Reproductive Health and
HIV Research Unit (RHRU), Johannesburg, South Africa; Makerere
University, Mulago Hospital, Kampala, Uganda). Funded by USAID,
United States. Clinical Trial Project Management of a Double-Blind
Randomized Placebo Controlled Dose-Finding Trial to Investigate
Different Doses of a New Antiviral Drug in Subjects with Genital
Herpes Simplex Virus (HSV) Type 2 Infection – Phase II (2009 –
2011) Co-Project Manager/Site Manager Responsibilities included
development of procedures, processes and study documents, overall
project operational management, GCP clinical monitoring of two
research sites (Virology Research Clinic (VRC), University of
Washington, Seattle and Westover Heights Clinic, Portland). Funded
by AiCuris GmbH & Co. KG, Germany.
http://www.delaneycare.org/
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 24 of 25
Development of Assays for Acute HIV Infection and Estimation of
HIV Incidence in Populations (2008 – 2010) Project Coordinator
Responsibilities included organizing a meeting of experts on HIV
incidence assays, generation of guidance documents on HIV incidence
assays with the World Health Organization (WHO), development of HIV
incidence library and management of sub-contracts. Funded by Bill
and Melinda Gates Foundation, United States. Project Management of
Continuous versus Cyclic Use of Combined Oral Contraceptive Pills
(2008 – 2012) Co-Project Manager/Site Manager Responsibilities
included development of procedures, processes and study documents,
project management, GCP clinical monitoring of two research sites
(Profamilia Clinic Santo Domingo, Dominican Republic and Profamilia
Clinic, Managua, Nicaragua). Funded by USAID, United States.
Clinical Trial Project Management of Medicines for Malaria Venture
(MMV) Phase III Pyramax® trials (2008 – 2010) Project
Manager/Clinical Trial Specialist Responsibilities included
supervision of regional monitoring staff, management of project
budgets, supervision of regulatory systems and project management
of three malaria sister clinical trials in sub-Saharan Africa.
Clinical Trial Research Management and Monitoring of Randomized
Controlled Trial of 6% Cellulose Sulfate Gel for Prevention of HIV
– Phase III (2005 – 2006) Clinical Research Manager/Monitor
Responsibilities included preparation of study documents, GCP
clinical monitoring of African sites (Makerere University, Mulago
Hospital, Kampala, Uganda; Medical Research Council (MRC), Durban,
South Africa; Project SIDA, Cotonou, Benin). Funded by Bill and
Melinda Gates Foundation and CONRAD, United States.
UNIVERSITY SERVICE 2017 – Present UNC Gillings School of Global
Public Health Global Health Concentration Committee 2017 – Present
Curriculum Committee, Public Health Leadership Program 2017 –
Present Emerging Leaders Program, UNC Gillings School of Global
Public Health 2017 MPH Integrated Core Development Committee, UNC
Gillings School of Global Public Health 2015 – Present UNC-CH
Endorsement Committee for the Rhodes Scholarship 2015 – Present
UNC-CH Morehead Scholarship Central Selection Committee 2010 –
Present UNC-CH Center for AIDS Research Community Advisory Board
2010 – Present UNC-CH Golden Fleece Foundation Board of
Directors
OTHER SERVICE/MEMBERSHIP 2019 – Present HIV Cure Target Product
Profile (TPP) Working Group, International AIDS Society and Bill
and
Melinda Gates Foundation 2019 – Present defeatHIV Collaboratory,
Fred Hutchinson Cancer Research Center 2019 – Present AIDS Clinical
Trials Group (ACTG) Transgender Working Group 2019 – Present Data
Sharing Working Group on HIV Cure Research 2019 – Present BEAT-HIV
Collaboratory, Wistar Institute 2018 ViiV Healthcare, CARLA
Implementation Protocol Review 2018 – Present Mentor,
Research-for-Cure Academy, International AIDS Society 2018 –
Present Women’s HIV Research Collaborative (WHRC), Member, United
States 2017 – Present International Social Sciences Working Group
on HIV Cure Research 2017 – Present National Martin Delaney
Community Advisory Board (CAB), At-Large Member, United States
-
Last Updated: February 12, 2020
Curriculum Vitae – Karine Dubé Page 25 of 25
EDITORIAL ACTIVITIES Associate Editor 2018 – Present BMC Public
Health, Infectious Diseases Epidemiology Section Academic Editor
2018 – Present PLoS One Peer Reviewer AIDS AIDS and Behavior AIDS
Patient Care and STDs American Journal of Empirical Bioethics
(AJOB) BMC Public Health Drug and Alcohol Dependence Global Public
Health HIV Medicine Journal of Acquired Immune Deficiency Syndromes
(JAIDS) Journal of the International AIDS Society (JIAS) Military
Medicine PLoS One
GRANT REVIEW 2019
• NIAID Clinical Trials Network Leadership and Operations Center
(LOC) Re-competition (UM1 Clinical Trial Required)
• AIDS Fonds Research, Netherlands (2019 Grant Round)
• Réseau SIDA, Maladies Infectieuses, Canada (2019 – 2020 Grant
Round)
• Réseau SIDA, Maladies Infectieuses, Canada (2018 – 2019 Grant
Round)